about
Mouse pulmonary adenoma susceptibility 1 locus is an expression QTL modulating Kras-4AComparative mapping of the actin-binding protein 280 genes in human and mouseA locus on mouse chromosome 2 is involved in susceptibility to congenital hypothyroidism and contains an essential gene expressed in thyroidMIF/CD74 axis is a target for novel therapies in colon carcinomatosis.Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomasDevelopment of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.Mouse genome-wide association mapping needs linkage analysis to avoid false-positive Loci.Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk.Multigenic nature of the mouse pulmonary adenoma progression 1 locusThe Lsktm1 locus modulates lung and skin tumorigenesis in the mouse.S100A11 overexpression contributes to the malignant phenotype of papillary thyroid carcinoma.Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization.High CD133 expression levels in gastrointestinal stromal tumors.Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells.Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells.Genetics of liver tumor susceptibility in mice.Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.Allele-specific patterns of the mouse parathyroid hormone-related protein: influences on cell adhesion and migration.Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients.Inhibition of both skin and lung tumorigenesis by Car-R mouse-derived cancer modifier loci.Cancer modifier alleles inhibiting lung tumorigenesis are common in inbred mouse strains.A V141L polymorphism of the human LRMP gene is associated with survival of lung cancer patients.Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice.Met proto-oncogene juxtamembrane rare variations in mouse and humans: differential effects of Arg and Cys alleles on mouse lung tumorigenesis.Inhibition of hepatitis B virus surface antigen gene expression in carcinogen-induced liver tumors from transgenic mice.Genetic control of resistance to hepatocarcinogenesis by the mouse Hpcr3 locus.Mapping of body weight loci on mouse chromosome X.Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2.Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response.Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci.Retina-derived POU domain factor 1 coordinates expression of genes relevant to renal and neuronal development.Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice.Pas1 haplotype-dependent genetic predisposition to lung tumorigenesis in rodents: a meta-analysis.Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosamine in the resistant BFF1 rat strain.4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.Expression quantitative trait analysis reveals fine germline transcript regulation in mouse lung tumors.Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors.A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6.Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis.Morphology, growth, and gene expression in five newly isolated murine hepatocellular tumor cell lines.
P50
Q27316056-9BC437BE-E4C0-4DBA-89F6-ED2A7950FC4BQ28248382-B3F56659-CAFF-4EFF-A33D-AC3F4621653CQ28565015-6A0A5884-D576-423B-9592-4292E30FECAFQ30836134-CB1BF4C0-147D-46F0-AAF8-51DCCF09EAF5Q33273701-F70EEF1A-B6DB-4345-89B4-72EF79BD0E65Q33275064-A88651C8-1AB4-4015-9DF7-1326A4336A3CQ33398543-E63B12C2-E566-4D08-A8F8-53CF787B7516Q34595709-55A4C152-30A7-4501-9149-2E55B0CF5A6EQ34622796-90A125E6-06D8-4C20-84FC-25D0D0EB7D46Q36196058-FEBD6EB6-5123-4999-9DCD-CFB761372F40Q39113324-6445F672-9EB2-47A4-8D5E-FFE20F6F02A3Q39260309-8B13AF9C-7C60-49C8-A811-A24CF26071D9Q39564970-20E39C9F-1E65-4611-8B2C-36BFFEE25EEEQ40302230-2BD991C0-A6CC-4A08-9A86-F4DF2CB9D043Q40701711-0079F496-993C-4E09-8B6C-4B66FDB04555Q40967225-B97955D0-5717-423C-8463-3631C189110CQ42450666-B920F0FB-137C-40AE-88DA-D54F1BEE4EC0Q42834555-3841FFDF-4739-4DF4-BEDB-9A4C15FF66AEQ43639835-31067D49-7D4F-4E5C-811A-7F4A4A240B0AQ43864428-808EB349-6D98-4984-9643-03FA1B10F4BAQ43981230-25631354-9FC6-4728-A90A-982C0B5B5662Q44512751-73E8CFC0-5F6E-4957-8A26-356AD019200EQ44830433-3BA8FB42-3AC1-40E6-91B7-BE4796A121BAQ45183639-7377D295-852A-4F68-8DB1-0684C82EF765Q45779013-0117E5F0-016E-46F7-BFCB-D52B2539D9E1Q46455725-12D90A4B-1A02-471A-A6BB-80C69A2DF521Q47344249-2573EE9E-A267-4F48-8D63-AF3FAC978C75Q48070560-84E61F71-621C-4748-B31E-EB25EA1DF002Q48263416-C9DBEFAC-C0D3-482B-98F2-77784F6C3A9DQ50106054-B9608370-CD35-4FB6-BE6B-4F263C4BB1F8Q50498224-E70F2C6B-545D-4DF3-8502-1B42766B2564Q51626774-0E5A6900-2932-4D7C-99FD-F44B6277132FQ51823002-8B9D2B57-A674-4887-BE3C-8494C320C1C2Q52176212-C838F09B-1727-4D2D-96CE-223D956AFCC5Q52928610-5F4ED1F1-F805-4DF6-887F-F0120ED296EDQ53151255-78F6871C-995D-42B5-BEA8-FE3A902FBEBEQ53320218-5230BFA5-E8F9-4215-9422-73288BEA8470Q53482353-D769EFFB-99AD-4B13-934C-03BBBBF10C11Q53536968-6E6267B9-12C8-4EC5-8577-1ABC0B1C3EF8Q54471107-D934E3F9-D75D-4312-B982-5775E0E2607D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giacomo Manenti
@ast
Giacomo Manenti
@en
Giacomo Manenti
@es
Giacomo Manenti
@nl
Giacomo Manenti
@sl
type
label
Giacomo Manenti
@ast
Giacomo Manenti
@en
Giacomo Manenti
@es
Giacomo Manenti
@nl
Giacomo Manenti
@sl
prefLabel
Giacomo Manenti
@ast
Giacomo Manenti
@en
Giacomo Manenti
@es
Giacomo Manenti
@nl
Giacomo Manenti
@sl
P1053
J-3339-2017
P106
P1153
7005287316
P21
P31
P3829
P496
0000-0002-4887-4482